Financials
- Market Capitalization 2.21 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
7.71
ratio cours/chiffre d'affaires
7.82
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1852 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.47 USD | +0.54% | -1.27% | -10.16% | +100.45% | 2.33 B USD | ||
| 1884 | IMNM Immunome, Inc. - Common Stock | 19.67 USD | +0.61% | -7.22% | -19.71% | +41.31% | 2.23 B USD | ||
| 1893 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.44 USD | -1.29% | +5.76% | +3.30% | +16.74% | 2.16 B USD | ||
| 1903 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 29.12 USD | -2.54% | -2.28% | -17.06% | -2.08% | 2.10 B USD |